Caption Management’s Oric Pharmaceuticals ORIC Stock Holding History

Caption Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Buy	+110,000	New	+$997K	0.01%	1077
2025 Q3	–	Sell	-996,200	Closed	-$10.1M	–	1946
2025 Q2	$10.1M	Buy	+996,200	New	+$6.69M	0.11%	202
2025 Q1	–	Sell	-135,000	Closed	-$1.09M	–	1897
2024 Q4	$1.09M	Buy	+135,000	New	+$1.24M	0.01%	890
2024 Q1	–	Sell	-200,000	Closed	-$1.84M	–	1557
2023 Q4	$1.84M	Buy	+200,000	New	+$1.45M	0.02%	642

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caption Management's ORIC Position: Q2 2026 in Review

Caption Management opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 48,130 shares worth $521K. The stake represents ﹤0.01% of the portfolio and ranks #1315 among its holdings. This is a return to the name: Caption Management previously reported a position in ORIC as recently as Q3 2025.

Caption Management first reported a position in ORIC in Q2 2023 and has held it in 5 quarters since. The position peaked at $876K in Q4 2023. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Caption Management held 48,130 shares of Oric Pharmaceuticals worth $521K as of Q2 2026.
Oric Pharmaceuticals was a new Caption Management position in Q2 2026.
Oric Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1315 holding.
Caption Management first reported a position in Oric Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
Caption Management's Oric Pharmaceuticals position peaked at $876K in Q4 2023.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.